Literature DB >> 3166574

Prostaglandin synthesis in the pathogenesis of fronto-ethmoidal mucoceles.

V J Lund1, W Harvey, S Meghji, M Harris.   

Abstract

The fronto-ethmoidal mucocele is a rare condition capable of expansion and erosion of bone. Its etiology is attributed to obstruction of the fronto-nasal duct and inflammation. To elucidate the role of inflammation, mucocele fragments and fibroblasts cultured from them were examined in vitro to assess prostaglandin E2 synthesis. The cultured fibroblasts when stimulated with mononuclear cell culture supernatant produced significant levels of prostaglandin E2 and collagenase, compared with normal frontal sinus mucosa fibroblasts removed at craniotomy. These significantly elevated mucocele levels of prostaglandin E2 (p = less than 0.001) suggest that lining fibroblasts are a major source of bone-resorbing factors, acting under the stimulus of lymphocytes and monocytes and which operate at the mucocele-bone interface, facilitating expansion. This situation closely parallels that already established in odontogenic cysts.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3166574     DOI: 10.3109/00016488809107382

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  4 in total

1.  [Pediatric acute dacryocystitis due to frontoethmoidal mucocele].

Authors:  J Heichel; H-G Struck; T Hammer; A Viestenz; S Plontke; A Glien
Journal:  HNO       Date:  2019-06       Impact factor: 1.284

2.  Ophthalmic manifestations of paranasal sinus mucocoeles.

Authors:  S Ahmed Sadiq; M Kim Lim; Nicholas S Jones
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

3.  Frontal sinus mucocele with orbital complications: Management by varied surgical approaches.

Authors:  Sushil Kumar Aggarwal; Kranti Bhavana; Amit Keshri; Raj Kumar; Arun Srivastava
Journal:  Asian J Neurosurg       Date:  2012-07

Review 4.  Surgery of the ethmoids--past, present and future: a review.

Authors:  V J Lund
Journal:  J R Soc Med       Date:  1990-07       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.